Hisamitsu Pharmaceutical Co., Inc.

TSE:4530 Stock Report

Market Cap: JP¥299.2b

Hisamitsu Pharmaceutical Dividends and Buybacks

Dividend criteria checks 4/6

Hisamitsu Pharmaceutical is a dividend paying company with a current yield of 2.11% that is well covered by earnings. Next payment date is on 26th May, 2025 with an ex-dividend date of 27th February, 2025.

Key information

2.1%

Dividend yield

5.8%

Buyback Yield

Total Shareholder Yield7.9%
Future Dividend Yield2.3%
Dividend Growth2.9%
Next dividend pay date26 May 25
Ex dividend date27 Feb 25
Dividend per shareJP¥86.000
Payout ratio66%

Recent dividend and buyback updates

Recent updates

Hisamitsu Pharmaceutical (TSE:4530) Has Announced A Dividend Of ¥45.00

Nov 27
Hisamitsu Pharmaceutical (TSE:4530) Has Announced A Dividend Of ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Has Announced A Dividend Of ¥45.00

Nov 08
Hisamitsu Pharmaceutical (TSE:4530) Has Announced A Dividend Of ¥45.00

We Think Hisamitsu Pharmaceutical (TSE:4530) Can Stay On Top Of Its Debt

Nov 04
We Think Hisamitsu Pharmaceutical (TSE:4530) Can Stay On Top Of Its Debt

Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Oct 17
Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations

Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Sep 16
Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 20
Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Jul 26
Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Jul 11
Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Jun 27
Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Jun 13
Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Apr 09
Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Mar 18
Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Upcoming Dividend Payment

TodayDec 24 2024Ex Dividend DateFeb 27 2025Dividend Pay DateMay 26 202588 days from Ex DividendBuy in the next 64 days to receive the upcoming dividend

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 4530's dividends per share have been stable in the past 10 years.

Growing Dividend: 4530's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Hisamitsu Pharmaceutical Dividend Yield vs Market
How does 4530 dividend yield compare to the market?
SegmentDividend Yield
Company (4530)2.1%
Market Bottom 25% (JP)1.8%
Market Top 25% (JP)3.8%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast (4530) (up to 3 years)2.3%

Notable Dividend: 4530's dividend (2.11%) is higher than the bottom 25% of dividend payers in the JP market (1.82%).

High Dividend: 4530's dividend (2.11%) is low compared to the top 25% of dividend payers in the JP market (3.81%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (65.7%), 4530's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (3583.8%), 4530's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 17:51
End of Day Share Price 2024/12/24 00:00
Earnings2024/08/31
Annual Earnings2024/02/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hisamitsu Pharmaceutical Co., Inc. is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Toshiro YoshinagaAizawa Securities Co. Ltd.
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Global Markets Japan Inc.